This prospective randomized comparative study was carried out after obtaining ethical committee approval at Ain Shams University Hospitals (reference number FMASU R 24/2023). Written informed consent was obtained from the patients’ parents or legal guardians. This trial was registered at ClinicalTrials.gov (reference number NCT05774132) with an initial registration date of March 17, 2023.
3.1. Study Population
Thirty children with spastic CP (American Society of Anesthesiologists (ASA) physical status II) aged 2 - 12 years who underwent elective unilateral lower limb multilevel soft tissue surgeries to correct knee and ankle deformities under general anesthesia in Ain Shams University hospitals from March 20, 2023, to September 27, 2023, were included. Patients were randomly assigned to 2 groups, CEB (caudal, n 15) and SNB (subgluteal sciatic nerve block, n = 15), using a computerized program and in a double-blind manner. For knee flexion deformity, tenotomy of semitendinosus with fractional lengthening of semimembranosus and biceps femoris was performed. Achilles tendon lengthening was performed using Z-plasty for the ankle equinus deformities.
Patients whose parents refused to provide written informed consent were excluded. Patients with dyskinetic-ataxic or mixed CP, need for corrective surgery for hip contracture/deformity, severe mental disability, active seizure disorders, poor respiratory function, marked renal or hepatic impairment, allergy to amide local anesthetics (LA), infection close to the block injection site, gross sacral deformities, or coagulopathy were also excluded.
3.2. Anesthetic Technique
A detailed preoperative anesthesia assessment of all patients, including a history of illness, previous anesthesia, medications, as well as physical examination and airway assessment, was performed. In addition, the laboratory investigations were revised. Instructions for preoperative fasting and continuation of medication were provided to the parents.
On the day of the operation, patient fasting was ensured, and skin was topicalized with EMLA cream at the suggested site for venous cannulation 1 hour before the surgery. Oral midazolam (0.25 mg/kg) premedication was administered 30 min before transfer to the operating room (OR). The parents were allowed to accompany their children to the OR holding area at which venous access was obtained, and Ringer’s solution infusion was started.
After transferring the patients to the OR, a 5-lead electrocardiogram (ECG), noninvasive arterial blood pressure monitoring, and pulse oximetry monitoring were initiated. A bispectral index (BIS) monitor and neuromuscular transmission module were used. If intravenous access was secured, premedication with intravenous atropine at a dose of 0.01 mg/kg and ondansetron 0.15 mg/kg was given; then, general anesthesia was induced using fentanyl 1 μg/kg, propofol 1.5 - 2 mg/kg (titrated according to BIS), and rocuronium 0.6 mg/kg. If the child was uncommunicative or combative, inhalational induction was done with sevoflurane 8% in a 50%:50% O2: air mixture with a head-up position of 20° to 30° and without positive pressure ventilation while trying to obtain intravenous access, followed by fentanyl, rocuronium, and premedications. A cuffed endotracheal tube was inserted, and the patients were mechanically ventilated to maintain normocapnia. An oropharyngeal temperature probe and a silicone urinary catheter were also inserted.
Patients were randomized into 2 equal groups by a third party not involved in perioperative patient management or data collection using a computerized program (groups CEB and SNB) according to the planned regional analgesic technique. Great caution was exercised to avoid exceeding the maximum dose of bupivacaine (2 mg/kg) during the LA injection in either group. A linear high-frequency US probe (5 - 13 MHz) was used in all blocks in both study groups and was performed by the same experienced anesthesiologist.
In the CEB Group: The patients received US-guided caudal analgesia after anesthesia induction. They were placed in a lateral position with meticulous attention paid to the suspected difficulties caused by pre-existing contractures and limb deformities. After adequate skin disinfection with povidone-iodine, the sacral hiatus was palpated, and the US probe was applied to the sacrococcygeal region in a transverse orientation. The sacral cornua could be identified as 2 hyperechoic reversed U-shaped structures (humps). Between the 2 sacral cornua, 2 hyperechoic lines could be identified; the superficial one was the sacrococcygeal ligament, and the inferior one was the dorsal surface of the sacral bone, while the sacral hiatus was the hypoechoic space between both lines (
Figure 1A). An echogenic 22-gauge 5-cm needle was inserted between the sacral cornua into the sacral hiatus utilizing (the out-of-plane approach) to penetrate the sacrococcygeal ligament (pop was felt), which was changed to a longitudinal orientation (90° rotation), and the needle was advanced into the caudal epidural space while visualizing the entire needle length and tip (in-plane approach) (
Figure 1B). Careful aspiration was done to confirm the absence of cerebrospinal fluid or blood. Then, 0.1 mL/kg of saline (0.9%) bolus was injected under US guidance to confirm the cranial spread of the injectate in the caudal epidural space while pushing the posterior dura mater anteriorly. Next, LA [bupivacaine 0.25% (1 mL/kg) without exceeding a maximum volume of 20 mL] was injected in increments of 1 mL every 5 seconds under full hemodynamic monitoring.
Ultrasound-guided caudal block. (A) Transverse scan of the sacrum at the level of caudal hiatus. Sc (sacral cornuae), SCM (sacrococcygeal membrane), (SH) sacral hiatus (B) longitudinal scan of sacral hiatus while introducing the block needle into the caudal epidural space. CES (caudal epidural space)
In the SNB Group: The patients received US-guided subgluteal sciatic nerve block after anesthesia induction. Each patient was placed in the lateral position, with the limb at which the nerve block was done in the uppermost position. After adequate skin disinfection with povidone-iodine, the probe was placed at the level of the gluteal crease midway between the 2 bony landmarks, the greater trochanter and ischial tuberosity (hyperechoic lines with acoustic shadowing); the gluteus maximus muscle was identified, and the sciatic nerve was hyperechoic and often elliptical and deep to this muscle (
Figure 2). An echogenic 22-gauge 5-cm needle was inserted utilizing the in-plane approach from lateral to medial targeting the sciatic nerve; the LA [bupivacaine 0.25% (0.3 mL/kg) without exceeding a maximum volume of 20 mL] was injected in increments of 1 mL every 5 seconds to surround the whole nerve circumference. Patients’ follow-up after the block (during and after surgery) was performed by an anesthesiologist blinded to the type of regional blockade.
Ultrasound-guided subgluteal sciatic nerve block. The LA was injected to surround the sciatic nerve in the targeted subgluteal plane. SN (sciatic nerve), GT (greater trochanter), (IT) ischial tuberosity, (GMM) gluteus maximus muscle, (LA) local anesthetic
Surgery was started 20 min after caudal or peripheral nerve block. Vital signs were recorded at 5-minute intervals while the blocks were being performed until the end of the surgery. Maintenance of anesthesia was provided with sevoflurane, which was adjusted according to the BIS monitoring targeting its value of 40 - 60, and incremental rocuronium (0.1 mg/kg) according to train-of-four monitoring (TOF). Care was taken during patient positioning, with adequate padding of the bony prominences to avoid pressure sores. All measures were taken to avoid hypothermia by maintaining the OR temperature at 24°C, warming the intravenous (IV) fluids to body temperature, and using warming blankets.
During surgery, insufficient analgesia was detected by a rise in the heart rate (HR) and mean arterial blood pressure by 20% or more above the baseline recordings. When that occurred, the patient was treated with a rescue dose of intravenous fentanyl (0.5 µg/kg), which could be repeated if required, and such cases were excluded from the study. Intraoperative bradycardia (> 20% decrease in HR below the baseline recordings) was controlled using atropine 0.01 mg/kg IV. When hypotension (MAP dropping below 50 mmHg) was detected, it was controlled by intravenous fluid bolus and incremental ephedrine (0.1 - 0.2 mg/kg) boluses, if needed.
After the termination of the surgical procedure, the inhalational anesthetic was discontinued, and the reversal of the residual muscle relaxant effect was done using IV neostigmine 0.05 mg/kg with atropine 0.02 mg/kg. Moreover, ETT was removed after the TOF was ≥ 0.9, restoration of gag reflex, and spontaneous eye opening, then the patients were transferred to the post-anesthesia care unit (PACU), where they stayed for the 2 hours observation period.
In the PACU, the children were allowed to have 1 parent stay with them until discharge. Vital sign monitoring was continued. Chest physiotherapy, suctioning of secretions, and oxygen supplementation were performed as required. After the PACU stay, the patients were admitted to either the surgical floor or the pediatric intermediate care unit at the discretion of the anesthesiologist and surgeon. The patients’ postoperative follow-up and data collection were performed by an anesthesiologist blinded to the type of the regional block received in each study group.
3.3. Measured Parameters
-The time to the first postoperative analgesia requirement was measured as the primary outcome.
-The Revised Face, Leg, Activity, Cry, Consolability (FLACC-R) pain scale score between 0 and 10 (
Table 1) (
14) was observed and recorded upon arrival to the PACU, every 2 hours for 1st 12 hours postoperatively and every 3 h for the next 12 h postoperatively. Patients with a score of 4 or greater received rescue analgesia by intravenous acetaminophen (perfalgan 15 mg/kg), and if the pain persisted after 15 minutes, another rescue analgesia by ketorolac 0.5 mg/kg IV (slowly) would be given.
| Categories | 0 | 1 | 2 |
|---|
| Individual Behaviors |
| Face | No particular expression or smile | Occasional grimace/frown; withdrawn or disinterested; appears sad or worried | Consistent grimace or frown; frequent/constant quivering chin, clenched jaw; distressed-looking face; expression, of fright or panic |
| Legs | Normal position or relaxed; usual tone and motion to limbs | Uneasy, restless, tense; occasional tremors | Kicking, or legs drawn up; marked increase in spasticity, constant tremors or jerking |
| Activity | Lying quietly in a normal position, moves easily; Regular, rhythmic respirations | Squirming, shifting back and forth; tense or guarded movements; mildly agitated (e.g., head back and forth, aggression); shallow, splinting respirations, intermittent sighs | Arched, rigid, or jerking; severe agitation, head banging, shivering (not rigors); breath-holding, gasping, or sharp intake of breaths; severe splinting |
| Cry | No cry/verbalization | Moans or whimpers; occasional complaint; occasional verbal outburst or grunt | Crying steadily, screams or sobs, frequent complaints; repeated outbursts, constant grunting |
| Consolability | Content and relaxed | Reassured by occasional touching, hugging, or being talked to; distractible | Difficult to console or comfort; pushing away the caregiver, resisting care or comfort measures |
Abbreviation: FLACC, face, legs, activity, cry, consolability.
- Total postoperative acetaminophen and ketorolac consumption during the first postoperative day
- Incidence of perioperative complications
- Parents’ satisfaction with the postoperative pain management of their children was examined using a 4-point scale (1 = very dissatisfied, 2 = dissatisfied, 3 = satisfied, and 4 = very satisfied).